Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial"-MedSci.cn

Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial"

Dong, HT; Lu, YL; Luo, YN

Dong, HT (corresponding author), Lanzhou Univ, Hosp 2, Dept Orthopaed, Lanzhou 730000, Gansu, Peoples R China.

INTERNATIONAL ORTHOPAEDICS, 2021; 45 (7): 1903

科室
- - 订阅+
  - 更多科室
工具
服务